HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maria J Pons Selected Research

Bartonella Infections (Bartonellosis)

7/2021Immunogenic Peptides from Pap31 and SCS-α of Bartonella bacilliformis: One Step Closer to a Rapid Diagnostic Tool for Carrion's Disease.
6/2017Immunosuppressive and angiogenic cytokine profile associated with Bartonella bacilliformis infection in post-outbreak and endemic areas of Carrion's disease in Peru.
11/2016Carrion's disease after blood transfusion.
3/2016Evaluation of PCR Approaches for Detection of Bartonella bacilliformis in Blood Samples.
1/2016Succinyl-CoA Synthetase: New Antigen Candidate of Bartonella bacilliformis.
5/2015An unidentified cluster of infection in the Peruvian Amazon region.
1/2014Diagnosis of Carrion's disease by direct blood PCR in thin blood smear negative samples.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maria J Pons Research Topics

Disease

7Bartonella Infections (Bartonellosis)
07/2021 - 01/2014
6Infections
01/2022 - 12/2007
3Bacteremia
11/2020 - 06/2017
2Whooping Cough (Pertussis)
11/2015 - 06/2015
1Salmonella Infections (Salmonellosis)
01/2022
1Inflammation (Inflammations)
01/2021
1COVID-19
01/2021
1Sepsis (Septicemia)
11/2020
1Asymptomatic Infections
06/2017
1Persistent Infection
06/2017
1Bacterial Infections (Bacterial Infection)
06/2017
1Enterobacteriaceae Infections
02/2017
1Fever (Fevers)
01/2016
1Glucosephosphate Dehydrogenase Deficiency
12/2015
1Anemia
01/2014
1Bacillary Dysentery (Shigellosis)
06/2009
1Diarrhea
12/2007

Drug/Important Bio-Agent (IBA)

4Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 06/2009
316S Ribosomal RNAIBA
03/2016 - 01/2014
2ChemokinesIBA
01/2021 - 06/2017
2Biomarkers (Surrogate Marker)IBA
01/2021 - 06/2017
2Interleukin-6 (Interleukin 6)IBA
01/2021 - 06/2017
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2021 - 06/2017
2CytokinesIBA
01/2021 - 06/2017
2Immunoglobulin M (IgM)IBA
06/2017 - 01/2016
2Immunoglobulin G (IgG)IBA
06/2017 - 01/2016
2Azithromycin (Zithromax)FDA LinkGeneric
02/2017 - 08/2015
2VaccinesIBA
11/2015 - 06/2015
1Pharmaceutical PreparationsIBA
01/2022
1Peptides (Polypeptides)IBA
07/2021
1CoagulaseIBA
11/2020
1Colistin (Coly-Mycin)FDA Link
10/2020
1Carbapenems (Carbapenem Antibiotics)IBA
09/2020
1Epidermal Growth Factor (EGF)IBA
06/2017
1SuspensionsIBA
06/2017
1Interleukin-10 (Interleukin 10)IBA
06/2017
1Interleukin-15 (Interleukin 15)IBA
06/2017
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2017
1AntigensIBA
01/2016
1DNA (Deoxyribonucleic Acid)IBA
01/2016
1EnzymesIBA
12/2015
1FluoroquinolonesIBA
08/2015
1Pertussis ToxinIBA
06/2015
1Third Generation CephalosporinsIBA
03/2015
1Ciprofloxacin (Cipro)FDA LinkGeneric
06/2009
1Rifaximin (L 105)FDA Link
12/2007

Therapy/Procedure

1Blood Transfusion (Blood Transfusions)
11/2016